Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kurt R. Klimpel is active.

Publication


Featured researches published by Kurt R. Klimpel.


Molecular Microbiology | 1994

Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity

Kurt R. Klimpel; Naveen Arora; Stephen H. Leppla

Comparison of the anthrax toxin lethal factor (LF) amino acid sequence with sequences in the Swiss protein database revealed short regions of similarity with the consensus zinc‐binding site, HEXXH, that is characteristic of metalloproteases. Several protease inhibitors, including bestatin and captopril, prevented intoxication of macrophages by lethal toxin. LF was fully inactivated by site‐directed mutagenesis that substituted Ala for either of the residues (H‐686 and H‐690) implicated in zinc binding. Similarly, LF was inactivated by substitution of Cys for E‐687, which is thought to be an essential part of the catalytic site. In contrast, replacement of E‐720 and E‐721 with Ala had no effect on LF activity. LF bound 65Zn both in solution and on protein blots. The 65Zn binding was reduced for several of the LF mutants. These data suggest that anthrax toxin LF is a zinc metallopeptidase, the catalytic function of which is responsible for the lethal activity observed in cultured cells and in animals.


Microbiology | 1996

Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies

Stephen F. Little; Jeanne M. Novak; John R. Lowe; Stephen H. Leppla; Yogendra Singh; Kurt R. Klimpel; Burton C. Lidgerding; Arthur M. Friedlander

Lethal toxin from Bacillus anthracis is composed of protective antigen (PA) and lethal factor (LF). Anti-PA mAbs that neutralized lethal toxin activity, either in vivo or in vitro, identified three non-overlapping antigenic regions on PA. Two distinct antigenic regions were recognized by the four mAbs that neutralized lethal toxin activity by inhibiting the binding of 125I-LF to cell-bound PA. Mapping showed that one mAb, 1G3PA63, recognized an epitope on a 17 kDa fragment located between amino acid residues Ser-168 and Phe-314. The three other mAbs, 2D3PA, 2D5PA and 10D2PA, recognized an epitope between amino acids Ile-581 and Asn-601. A single antigenic region was recognized by the three mAbs, 3B6PA, 14B7PA and 10E10PA63, that inhibited binding of 125I-PA to cells. This region was located between amino acids Asp-671 and Ile-721. These results confirm previously defined functional domains of PA and suggest that LF may interact with two different sites on PA to form lethal toxin.


Human Immunology | 1997

Delivery of antigens to the MHC class I pathway using bacterial toxins.

Theresa J. Goletz; Kurt R. Klimpel; Stephen H. Leppla; Jerry M. Keith; Jay A. Berzofsky

Cytotoxic T lymphocytes (CTL) recognize antigens derived from endogenously expressed proteins presented on the cell surface in the context of major histocompatibility complex (MHC) class I molecules. Because CTL are effective in antiviral and antitumor responses, the delivery of antigens to the class I pathway has been the focus of numerous efforts. Generating CTL by immunization with exogenous proteins is often ineffective because these antigens typically enter the MHC class II pathway. This review focuses on the usefulness of bacterial toxins for delivering antigens to the MHC class I pathway. Several toxins naturally translocate into the cytosol, where they mediate their cytopathic effects, and the mechanisms by which this occurs has been elucidated. Molecular characterization of these toxins identified the functional domains and enabled the generation of modified proteins that were no longer toxic but retained the ability to translocate into the cytosol. Thus, these modified toxins could be examined for their ability to carry peptides or whole proteins into the cytosolic processing pathway. Of the toxins studied-diphtheria, pertussis, Pseudomonas, and anthrax-the anthrax toxin appears the most promising in its ability to deliver large protein antigens and its efficiency of translocation.


Archive | 1994

Anthrax toxin mechanisms of receptor binding and internalization

Stephen H. Leppla; Kurt R. Klimpel; Naveen Arora

The anthrax toxin complex contains two catalytic proteins, edema factor (EF) and lethal factor (LF), which must be translocated to the cytosol of eukaryotic cells to cause toxicity. The third protein component of the toxin, protective antigen (PA), achieves this internalization. PA binds to cell surface receptors, is cleaved after the sequence Argl64-Lysl65-Lysl66-Argl67 by a cell surface protease, and thereby exposes a binding site to which EF or LF bind with high affinity. The complexes enter endosomes, which then become acidified, causing transfer of LF and EF to the cytosol.


Science | 1998

Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor

Nicholas S. Duesbery; Craig P. Webb; Stephen H. Leppla; Valery M. Gordon; Kurt R. Klimpel; Terry D. Copeland; Natalie G. Ahn; M Oskarsson; Kenji Fukasawa; Ken D. Paull; George F. Vande Woude


Nature | 1997

Crystal structure of the anthrax toxin protective antigen

C Petosa; R. J. Collier; Kurt R. Klimpel; Stephen H. Leppla; Robert C. Liddington


Infection and Immunity | 1995

Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.

Valery M. Gordon; Kurt R. Klimpel; N Arora; M A Henderson; Stephen H. Leppla


Infection and Immunity | 1999

Oligomerization of Anthrax Toxin Protective Antigen and Binding of Lethal Factor during Endocytic Uptake into Mammalian Cells

Yogendra Singh; Kurt R. Klimpel; Seema Goel; Prabodha K. Swain; Stephen H. Leppla


Journal of Biological Chemistry | 1992

Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.

Naveen Arora; Kurt R. Klimpel; Yogendra Singh; Stephen H. Leppla


Journal of Biological Chemistry | 1994

The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.

Yogendra Singh; Kurt R. Klimpel; Naveen Arora; Manju Sharma; Stephen H. Leppla

Collaboration


Dive into the Kurt R. Klimpel's collaboration.

Top Co-Authors

Avatar

Naveen Arora

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Stephen H. Leppla

Government of the United States of America

View shared research outputs
Top Co-Authors

Avatar

Theresa J. Goletz

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Yogendra Singh

Government of the United States of America

View shared research outputs
Top Co-Authors

Avatar

Jay A. Berzofsky

Government of the United States of America

View shared research outputs
Top Co-Authors

Avatar

Jerry M. Keith

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

John B. Robbins

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arthur M. Friedlander

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge